Secondary cancers, Womb (uterine or endometrial) cancer
Results
Phase 2
This trial looked at dovitinib for womb (endometrial) cancer that had got worse despite treatment. It was for women who had already had one course of chemotherapy for advanced womb cancer.
Recruitment start: 17 February 2012
Recruitment end: 13 December 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rebecca Kristeleit
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 29 Nov 2018
CRUK internal database number: 9480
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
